RMD peers and competitors
ResMed Inc. · end-of-day data as of Oct 16, 2026
ResMed Inc.
$238.97+22.7%
Buy · 20 analystsPT $247.91 +3.7%
RMD’s peers by industry and size include Intuitive Surgical (ISRG), Becton, Dickinson (BDX) and Biogen (BIIB). Among these 12 companies RMD ranks 5th by market cap ($33.61B); its P/E of 23.0 compares with a median of 36.5 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $426.70 | -0.3% | -28.0% | +12.1% | 48.5 | $151B | |
| 2 |  | $191.75 | -1.0% | -1.0% | -6.2% | 57.8 | $52.23B | |
| 3 |  | $232.65 | -1.1% | -1.1% | +2.7% | 41.2 | $34.37B | |
| 4 |  | $69.16 | -1.9% | -1.9% | -0.5% | — | $34.16B | |
| 5 | | $238.97 | -1.3% | -12.7% | +3.7% | 23.0 | $33.61B | |
| 6 |  | $79.38 | +1.2% | -45.2% | +24.2% | 13.1 | $32.78B | |
| 7 |  | $1,622.29 | -1.0% | -1.0% | -7.3% | 36.5 | $32.51B | |
| 8 |  | $86.04 | -1.9% | -6.8% | +12.7% | 34.0 | $32.47B | |
| 9 |  | $384.02 | +0.3% | 0.0% | +1.9% | 49.1 | $27.03B | |
| 10 |  | $85.81 | -2.3% | -7.2% | +3.6% | 10.5 | $14.61B | |
| 11 |  | $25.28 | -1.9% | -10.8% | -14.8% | — | $13.07B | |
| 12 |  | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B |
Data as of Oct 16, 2026 close.